SELENIUM-CONTAINING NOVEL ZINC (II) ORGANIC COMPLEX HAVING HYPOGLYCEMIC ACTION

摘要

PROBLEM TO BE SOLVED: To provide a therapeutic agent raw material capable of oral administration in lieu of insulin where there is a treatment method which only relay on subcutaneous injection of insulin for type 1 diabetes.;SOLUTION: There is provided a pharmaceutical raw material consisting of a zinc (II) organic complex containing a compound consisting of 3-hydroxy-4H-pyran-4-selenone having a γ-pyrone ring and a derivative thereof or the like as a ligand, having insulin-like action and hypoglycemic action and capable of replacing existing therapeutic agents for diabetes.;SELECTED DRAWING: None;COPYRIGHT: (C)2017,JPO&INPIT